Willow Biosciences, Inc. is a biotechnology company. It develops synthetic biology solutions for opioid biosynthesis. The firm offers biosynthetic production systems for plant-derived active pharmaceutical ingredients (API) and intermediates. The company was founded on April 12, 2019 and is headquartered in Calgary, Canada.
Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CT:WLLW.
$0.08 OTCQB
As of 01/27/2023 OTCMarkets
2022 © Stock Market MBA, Inc.